Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS
Public ClinicalTrials.gov record NCT00559962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate Low Doses of the MTP-Inhibitor AEGR-733 on Hepatic Fat Accumulation as Measured by Magnetic Resonance Spectroscopy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine safety and effectiveness of low-dose therapeutic AEGR-733 +/- atorvastatin, ezetimibe or fenofibrate (compared to placebo) on liver fat accumulation measured by Magnetic Resonance Spectroscopy
Study identification
- NCT ID
- NCT00559962
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 260 participants
Conditions and interventions
Conditions
Interventions
- AEGR-733 Drug
- placebo Drug
- AEGR-733 and atorvastatin Drug
- AEGR-733 and fenofibrate Drug
- AEGR-733 and ezetimibe Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2007
- Primary completion
- Sep 30, 2008
- Completion
- Oct 31, 2008
- Last update posted
- Feb 22, 2018
2007 – 2008
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scripps Clinic | San Diego | California | 92128 | — |
| Radiant Research | Santa Rosa | California | 95405 | — |
| MedStar Research Institute | Washington D.C. | District of Columbia | 20003 | — |
| Radiant Research | Chicago | Illinois | 60610 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| LMARC | Louisville | Kentucky | 40213 | — |
| Maine Research Associates | Auburn | Maine | 04210 | — |
| Health Trends Research | Baltimore | Maryland | 21209 | — |
| Johns Hopkins | Baltimore | Maryland | 21287 | — |
| Washington Univ. School of Medicine | St Louis | Missouri | 63110 | — |
| Sterling Research Group | Cincinnati | Ohio | 45219 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Clinical Trial Network | Houston | Texas | 77074 | — |
| dgd Research | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00559962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2018 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00559962 live on ClinicalTrials.gov.